Bicara Therapeutics Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan | President and COO | Option Exercise | 25,000 | $4.44 | $111,000 | 214,141 | Dec 26, 2025 |
| Raben David | Chief Medical Officer | Option Exercise | 19,789 | $3.79 | $75,000 | 55,286 | Dec 26, 2025 |
| Hyep Ivan | Chief Financial Officer | Sale | 9,200 | $18.31 | $168,452 | 145,355 | Dec 22, 2025 |
| Mazumdar Claire | Chief Executive Officer | Option Exercise | 29,500 | $5.45 | $160,775 | 339,392 | Dec 16, 2025 |
| Cohlhepp Ryan | President and COO | Option Exercise | 8,000 | $3.79 | $30,320 | 201,641 | Dec 15, 2025 |
| Raben David | Chief Medical Officer | Sale | 4,594 | $18.84 | $86,551 | 35,497 | Nov 25, 2025 |
| Mazumdar Claire | Chief Executive Officer | Option Exercise | 41,163 | $3.79 | $156,008 | 351,055 | Nov 24, 2025 |
| Hyep Ivan | Chief Financial Officer | Sale | 605 | $18.15 | $10,981 | 145,355 | Nov 21, 2025 |
| Cohlhepp Ryan | President and COO | Sale | 8,000 | $18.05 | $144,400 | 198,141 | Nov 21, 2025 |
| Mazumdar Claire | Chief Executive Officer | Option Exercise | 24,103 | $3.79 | $91,350 | 333,995 | Oct 16, 2025 |
| Cohlhepp Ryan | President and COO | Option Exercise | 8,000 | $3.79 | $30,320 | 210,641 | Oct 15, 2025 |
| Mazumdar Claire | Chief Executive Officer | Option Exercise | 11,445 | $3.79 | $43,377 | 321,337 | Oct 13, 2025 |
| Raben David | Chief Medical Officer | Sale | 22,000 | $18.45 | $405,900 | 35,497 | Oct 9, 2025 |
| Hyep Ivan | Chief Financial Officer | Sale | 6,415 | $18.23 | $116,945 | 145,355 | Oct 9, 2025 |
| Hyep Ivan | Chief Financial Officer | Option Exercise | 6,514 | $3.79 | $24,688 | 151,869 | Oct 7, 2025 |
| Cohlhepp Ryan | President and COO | Option Exercise | 24,000 | $3.79 | $90,960 | 245,141 | Oct 7, 2025 |
| Meisner Lara | Chief Legal Officer | Sale | 33,807 | $14.75 | $498,653 | — | Sep 29, 2025 |
| Meisner Lara | Chief Legal Officer | Option Exercise | 15,829 | $5.45 | $86,268 | 15,829 | Sep 15, 2025 |
| Meisner Lara | Chief Legal Officer | Option Exercise | 15,829 | $5.45 | $86,268 | 15,829 | Jun 16, 2025 |
| Meisner Lara | Chief Legal Officer | Option Exercise | 79,146 | $5.45 | $431,346 | 79,145 | Mar 14, 2025 |
| Deerfield Private Design Fund V, L.P. | — | Purchase | 35,000 | $18.00 | $630,000 | 897,587 | Sep 17, 2024 |
| RA Capital Nexus Fund III, L.P. | — | C | 2,622,898 | — | — | 2,622,898 | Sep 16, 2024 |
| BONDERMAN DAVID | — | C | 1,960,425 | — | — | 1,960,425 | Sep 16, 2024 |
| FIL Ltd | — | C | 54,092 | — | — | 54,092 | Sep 16, 2024 |
| FMR LLC | — | C | 392,085 | — | — | 1,115,333 | Sep 16, 2024 |
| Biocon Ltd | — | C | 4,327,365 | — | — | 4,443,122 | Sep 16, 2024 |
| Mazumdar-Shaw Kiran | — | C | 324,552 | — | — | 324,552 | Sep 16, 2024 |